Published in

Elsevier, The Lancet Oncology, 7(11), p. 646-652

DOI: 10.1016/s1470-2045(10)70104-2

Links

Tools

Export citation

Search in Google Scholar

Size of sentinel-node metastasis and chances of non-sentinel-node involvement and survival in early stage vulvar cancer: results from GROINSS-V, a multicentre observational study.

Journal article published in 2010 by Maaike H. Oonk, Bettien M. van Hemel, Harry Hollema, Joanne A. de Hullu, B. M. van Hemel, Anca C. Ansink, Ignace Vergote, J. A. de Hullu, René H. Verheijen, Eleonora B. van Dorst, Angelo Maggioni, Jacobus van der Velden, Katja N. Gaarenstroom ORCID, Peter J. Baldwin, Hans W. van der Putten and other authors.
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

BACKGROUND: Currently, all patients with vulvar cancer with a positive sentinel node undergo inguinofemoral lymphadenectomy, irrespective of the size of sentinel-node metastases. Our study aimed to assess the association between size of sentinel-node metastasis and risk of metastases in non-sentinel nodes, and risk of disease-specific survival in early stage vulvar cancer. METHODS: In the GROningen INternational Study on Sentinel nodes in Vulvar cancer (GROINSS-V), sentinel-node detection was done in patients with T1-T2 (